Commentary: Efficacy and Safety of Dupilumab in Moderate-to-Severe Bullous Pemphigoid

Commentary: Efficacy and Safety of Dupilumab in Moderate-to-Severe Bullous Pemphigoid

Guardado en:
Detalles Bibliográficos
Autores principales: Si-Hang Wang, Ya-Gang Zuo
Formato: article
Lenguaje:EN
Publicado: Frontiers Media S.A. 2021
Materias:
bullous pemphigoid
dupilumab
treatment
IL-4
IL-13
Immunologic diseases. Allergy
RC581-607
Acceso en línea:https://doaj.org/article/4da850d5fffc4d758b2104aac24473b3
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:4da850d5fffc4d758b2104aac24473b3
record_format dspace
spelling oai:doaj.org-article:4da850d5fffc4d758b2104aac24473b32021-11-30T12:17:06ZCommentary: Efficacy and Safety of Dupilumab in Moderate-to-Severe Bullous Pemphigoid1664-322410.3389/fimmu.2021.800609https://doaj.org/article/4da850d5fffc4d758b2104aac24473b32021-11-01T00:00:00Zhttps://www.frontiersin.org/articles/10.3389/fimmu.2021.800609/fullhttps://doaj.org/toc/1664-3224Si-Hang WangYa-Gang ZuoFrontiers Media S.A.articlebullous pemphigoiddupilumabtreatmentIL-4IL-13Immunologic diseases. AllergyRC581-607ENFrontiers in Immunology, Vol 12 (2021)
institution DOAJ
collection DOAJ
language EN
topic bullous pemphigoid
dupilumab
treatment
IL-4
IL-13
Immunologic diseases. Allergy
RC581-607
spellingShingle bullous pemphigoid
dupilumab
treatment
IL-4
IL-13
Immunologic diseases. Allergy
RC581-607
Si-Hang Wang
Ya-Gang Zuo
Commentary: Efficacy and Safety of Dupilumab in Moderate-to-Severe Bullous Pemphigoid
format article
author Si-Hang Wang
Ya-Gang Zuo
author_facet Si-Hang Wang
Ya-Gang Zuo
author_sort Si-Hang Wang
title Commentary: Efficacy and Safety of Dupilumab in Moderate-to-Severe Bullous Pemphigoid
title_short Commentary: Efficacy and Safety of Dupilumab in Moderate-to-Severe Bullous Pemphigoid
title_full Commentary: Efficacy and Safety of Dupilumab in Moderate-to-Severe Bullous Pemphigoid
title_fullStr Commentary: Efficacy and Safety of Dupilumab in Moderate-to-Severe Bullous Pemphigoid
title_full_unstemmed Commentary: Efficacy and Safety of Dupilumab in Moderate-to-Severe Bullous Pemphigoid
title_sort commentary: efficacy and safety of dupilumab in moderate-to-severe bullous pemphigoid
publisher Frontiers Media S.A.
publishDate 2021
url https://doaj.org/article/4da850d5fffc4d758b2104aac24473b3
work_keys_str_mv AT sihangwang commentaryefficacyandsafetyofdupilumabinmoderatetoseverebullouspemphigoid
AT yagangzuo commentaryefficacyandsafetyofdupilumabinmoderatetoseverebullouspemphigoid
_version_ 1718406619086192640

Ejemplares similares